|
Name |
Cytochalasin Z28
|
Molecular Formula | C30H37NO6 | |
IUPAC Name* |
(1S,5E,8S,10E,12S,13S,15S,17S)-13-hydroxy-17-[(4-hydroxyphenyl)methyl]-6,8,15-trimethyl-14-propan-2-ylidene-2-oxa-18-azatricyclo[10.7.0.01,16]nonadeca-5,10-diene-3,7,19-trione
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H](C(=C(C)C)[C@H](C3[C@]2(C(=O)N[C@H]3CC4=CC=C(C=C4)O)OC(=O)C/C=C(/C1=O)\C)C)O
|
|
InChI |
InChI=1S/C30H37NO6/c1-16(2)25-19(5)26-23(15-20-10-12-21(32)13-11-20)31-29(36)30(26)22(28(25)35)8-6-7-17(3)27(34)18(4)9-14-24(33)37-30/h6,8-13,17,19,22-23,26,28,32,35H,7,14-15H2,1-5H3,(H,31,36)/b8-6+,18-9+/t17-,19+,22-,23-,26?,28-,30+/m0/s1
|
|
InChIKey |
WNLXIJVAWRHENW-XNAJFPMCSA-N
|
|
Synonyms |
Cytochalasin Z28
|
|
CAS | NA | |
PubChem CID | 139588560 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 507.6 | ALogp: | 3.3 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 113.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 37 | QED Weighted: | 0.402 |
Caco-2 Permeability: | -4.776 | MDCK Permeability: | 0.00005990 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.981 |
Human Intestinal Absorption (HIA): | 0.05 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.613 | Plasma Protein Binding (PPB): | 98.79% |
Volume Distribution (VD): | 0.79 | Fu: | 2.36% |
CYP1A2-inhibitor: | 0.046 | CYP1A2-substrate: | 0.085 |
CYP2C19-inhibitor: | 0.421 | CYP2C19-substrate: | 0.421 |
CYP2C9-inhibitor: | 0.549 | CYP2C9-substrate: | 0.087 |
CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.096 |
CYP3A4-inhibitor: | 0.912 | CYP3A4-substrate: | 0.385 |
Clearance (CL): | 11.032 | Half-life (T1/2): | 0.058 |
hERG Blockers: | 0.095 | Human Hepatotoxicity (H-HT): | 0.41 |
Drug-inuced Liver Injury (DILI): | 0.86 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.636 | Maximum Recommended Daily Dose: | 0.941 |
Skin Sensitization: | 0.168 | Carcinogencity: | 0.434 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.982 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003672 | 0.743 | D0S2BV | 0.265 | ||||
ENC004801 | 0.612 | D06XZW | 0.264 | ||||
ENC001865 | 0.593 | D0S0LZ | 0.233 | ||||
ENC004119 | 0.466 | D0FX2Q | 0.232 | ||||
ENC004372 | 0.446 | D04UTT | 0.226 | ||||
ENC002183 | 0.444 | D0SP3D | 0.225 | ||||
ENC002622 | 0.431 | D09NNH | 0.225 | ||||
ENC004371 | 0.430 | D0V3ZA | 0.224 | ||||
ENC002161 | 0.423 | D0Q0PR | 0.222 | ||||
ENC005176 | 0.420 | D01XDL | 0.221 |